| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1339677B1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1309557B1 Amlodipine hemimaleate |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1292306B1 A combination kit used in the treatment of malaria containing chloroquine and bulaquine |
| 01/04/2006 | EP1284754B1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 01/04/2006 | EP1265621B1 Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1237553B1 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1212000B1 System for controlling body temperature while reducing shivering |
| 01/04/2006 | EP1206476B1 9a-azalides with antibacterial activity |
| 01/04/2006 | EP1189886B1 Ethanesulfonyl-piperidine derivatives |
| 01/04/2006 | EP1173172B1 Synergistic effects of amlodipine and the hydroxylated metabolite of atorvastatin |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1154749A4 An aqueous non-alcoholic oral rinse containing benzocaine and carbomer |
| 01/04/2006 | EP1150681B1 Use of a pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1147772B1 Use of 1,4-benzothiazepine derivatives for the preparation of a medicament FOR the TREATMENT OF ATRIAL FIBRILLATION |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP1146881B1 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 01/04/2006 | EP1131051B1 Pressurised metered dose inhalers (mdi) |
| 01/04/2006 | EP1129079B1 2,4-disubstituded triazine derivatives with anti hiv activity |
| 01/04/2006 | EP1128844B1 Botulinum toxins for enhancing wound healing |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | EP1070083B1 Crystalline forms of 1s- [1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- [[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino [1, 2-a][ 1,2] diazepine-1-carboxamide |
| 01/04/2006 | EP1064004B1 Metal/thiol biocides |
| 01/04/2006 | EP1044008B1 Use of aliphatic polyamines for reducing oxalate |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | EP0970243B1 Diagnosis and treatment of glaucoma |
| 01/04/2006 | EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 01/04/2006 | EP0932399B1 Water soluble paclitaxel prodrugs |
| 01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
| 01/04/2006 | EP0820286B1 Tetrandrine for the treatment for ocular inflammation |
| 01/04/2006 | EP0804609B1 NOVEL p53 RESPONSE GENES |
| 01/04/2006 | EP0786990B1 Use of astaxanthin for retarding and ameliorating eye damage |
| 01/04/2006 | CN1717497A Treatment of huntington's disease with EPA |
| 01/04/2006 | CN1717494A Beta-1,4-mannobiose-containing composition |
| 01/04/2006 | CN1717493A Process for producing macrolide compound |
| 01/04/2006 | CN1717414A Promoter for the production of hyaluronic acid containing ginsenoside compound K |
| 01/04/2006 | CN1717409A Pyrazolonaphthyridine derivative |
| 01/04/2006 | CN1717408A Carbamic acid esters with anticholinergic activity |
| 01/04/2006 | CN1717407A Indolyl derivatives |
| 01/04/2006 | CN1717405A Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 01/04/2006 | CN1717401A Anilinopyrazole derivatives useful for the treatment of diabetes |
| 01/04/2006 | CN1717397A 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717391A Inhibitors of glycogen synthase kinase 3 |
| 01/04/2006 | CN1717390A Piperazine and piperidine derivatives for treatment of neurological diseases |
| 01/04/2006 | CN1717389A Phenyl substituted piperidine compounds for use as PPAR activators |
| 01/04/2006 | CN1717321A Multilaminate backing construction |
| 01/04/2006 | CN1717268A Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |
| 01/04/2006 | CN1717253A Solid preparation |
| 01/04/2006 | CN1717252A Preparation containing basic drug |
| 01/04/2006 | CN1717250A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/04/2006 | CN1717245A Medicinal composition |
| 01/04/2006 | CN1717240A New use of dextran sulfate |
| 01/04/2006 | CN1717239A Transdermal therapeutic system containing testosterone and method for the production thereof |
| 01/04/2006 | CN1717238A Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 01/04/2006 | CN1717237A Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| 01/04/2006 | CN1717236A Method of treatment of transplant rejection |
| 01/04/2006 | CN1717235A Method of treating movement disorders using barbituric acid derivatives |
| 01/04/2006 | CN1717234A Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 01/04/2006 | CN1717233A 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 01/04/2006 | CN1717232A Use of l-carnitine for the treatment of cardiovascular diseases |
| 01/04/2006 | CN1717231A Lysine mixture and apparatus and method for administering lysine |
| 01/04/2006 | CN1717230A Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor |
| 01/04/2006 | CN1717229A Composition and its use for treating neuropathic sensory loss |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1717227A Pharmaceutical compositions comprising flavonoids and menthol |
| 01/04/2006 | CN1717226A Warm poultice |
| 01/04/2006 | CN1717225A Tiotropium containing powder formulation for inhalation |
| 01/04/2006 | CN1717224A Therapeutic compositions |
| 01/04/2006 | CN1717223A Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 01/04/2006 | CN1717222A Method of drug loading in liposomes by gradient |
| 01/04/2006 | CN1717221A Method of drug loading in liposomes by gradient |
| 01/04/2006 | CN1717220A Liposomal formulations |
| 01/04/2006 | CN1717219A Microemulsion composition for oral administration of biphenyldimethyldicarboxylate |
| 01/04/2006 | CN1717184A Methods and compositions for providing glutamine |
| 01/04/2006 | CN1717183A Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals |
| 01/04/2006 | CN1715298A Ganodema tsugae-proteoglycan and its preparing method and use |
| 01/04/2006 | CN1715292A Cerbera manghas heteroside derivative, its preparing method and use |
| 01/04/2006 | CN1715291A Synthesis of oleanolic acid succinic acid monoester and its medicinal preparation for treating chronic and acute hepatitis |
| 01/04/2006 | CN1715288A Process for preparing high purity breviscapine B raw material medicine |
| 01/04/2006 | CN1715283A Novel garcinolic acid derivative and its preparing method and use |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1715279A Repinotan analogue,its preparing method and use |
| 01/04/2006 | CN1715277A Compound for treating cardiocerebral vascular disease and its preparing method and its use in pharmaceutical field |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1715262A Peroxisome propogation agent activating receptor gamma ligand excitomotor and its use |
| 01/04/2006 | CN1714874A Absorptive bone hemostatic agent |
| 01/04/2006 | CN1714871A Use of human ING4 gene as chemotherapy medicine sensitivity promoter |
| 01/04/2006 | CN1714869A Anhydrous topical skin preparations |
| 01/04/2006 | CN1714868A Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 01/04/2006 | CN1714867A Triacetin as a transdermal penetration enhancer |
| 01/04/2006 | CN1714866A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 01/04/2006 | CN1714810A Drugs, foods, drinks and feeds containing cocoa component |